Affiliated with a Castle Connolly Top Hospital
Who is Dr. Moshfeghi, Retina Specialist in Stanford, CA?
Dr. Darius Moshfeghi, MD is a Retina Specialist, who primarily practices in Stanford, CA with 1 additional practice location. He is board certified. Dr. Moshfeghi completed his residency at Tulane Univ Sch Of Med, Ophthalmology; Tulane Univ Hosp & Clis, Flexible Or Transitional Year. Dr. Moshfeghi is fluent in English, and is currently seeing new patients. Dr. Moshfeghi’s practice accepts Kaiser Permanente, Medicaid, Medicare, Aetna, Cigna, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Moshfeghi’s office at (650) 723-4000.
What are Areas of Expertise for Dr. Moshfeghi?
Dr. Darius Moshfeghi, MD is a highly-rated, board-certified Retina Specialist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Moshfeghi empowers patients to confidently navigate their health journey, specializing in Macular Degeneration, Pediatric Ophthalmology, Retina/Vitreous Surgery, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Moshfeghi is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Moshfeghi go to medical school and complete their residency?
Residency: Tulane Univ Sch Of Med, Ophthalmology; Tulane Univ Hosp & Clis, Flexible Or Transitional Year | Tulane University Hospital and Clinic
Medical School: Tulane Univ Sch of Med, New Orleans La
Is Dr. Moshfeghi board certified as a Retina Specialist?
Yes, Dr. Darius Moshfeghi, MD is board certified by the American Board of Ophthalmology
What languages does Dr. Moshfeghi speak?
Dr. Moshfeghi and their clinical team can communicate with patients in the following languages:
English
What conditions does a Retina Specialist like Dr. Moshfeghi typically treat?
As a Retina Specialist, Dr. Moshfeghi diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Moshfeghi. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology here.
Also known as:
- Retinopathy of Prematurity
- Premature Babies
- Retinal Disorder
- ROP
- Premature Retinopathy
- Retinal Disease in Premature Babies
ICD-10 Codes:
- H35113: Retinopathy of prematurity, stage 0, bilateral
Also known as:
- Wet Macular Degeneration
- Dry Macular Degeneration
- Macular Degeneration
- Exudative AMD
- Neovascular Macular Degeneration
- Wet AMD
- Dry AMD
- Atrophic Macular Degeneration
- Age-related Macular Degeneration (Dry)
ICD-10 Codes:
- H353231: Exudative age-related macular degeneration, bilateral, with active choroidal neovascularization
- H353132: Nonexudative age-related macular degeneration, bilateral, intermediate dry stage
Also known as:
- Severe nearsightedness
- Refractive Errors
- Pathologic myopia
- High myopia
- Progressive nearsightedness
ICD-10 Codes:
- H4423: Degenerative myopia, bilateral
What procedures does a Retina Specialist like Dr. Moshfeghi typically perform?
As a Retina Specialist, Dr. Moshfeghi performs a variety of medical procedures. This procedure information is derived from anonymized insurance claims and highlights the medical procedures most commonly performed by Dr. Moshfeghi. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology here.
Also known as:
- Eye Injection
- Intravitreal Injection
- Retinal Injection
- Macular Degeneration Injection
- Eye Medication Injection
CPT Codes:
- 67028: Intravitreal injection of a pharmacologic agent (separate procedure)
Also known as:
- Laser Treatment for Retinopathy
- Photocoagulation for Retinopathy
- Diabetic Retinopathy Laser Treatment
- Retinal Laser Therapy
CPT Codes:
- 67228: Treatment of extensive or progressive retinopathy (eg, diabetic retinopathy), photocoagulation
Does Dr. Moshfeghi accept my insurance?
Dr. Moshfeghi accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Moshfeghi accept in Stanford, CA?
Dr. Moshfeghi in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
Centene Corporation
CVS Health (formerly Aetna)
Elevance Health Inc. (formerly Anthem)
Medicare
Santa Cruz County
State of California
UnitedHealth Group
Unknown
View All Insurances
Where is Dr. Moshfeghi's office located?
Recognitions
Publications
Exudative retil detachment following photocoagulation
, 2014
Persistent plus disease after laser in retinopathy of prematurity with tetralogy of Fallot
, 2013
Academic productivity
, 2013
Fundus Findings in Chronic Granulomatous Disease
, 2013
16 and 24 Gy Low-voltage X-ray Irradiation With Ranibizumab Therapy for Neovascular Age-Related
, 2013
The importance of keeping a broad differential in reti clinic
, 2013
Herpes simplex virus type 2 mediated acute retil necrosis in a pediatric population
, 2013
Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP)
, 2013
Human histopathology of PASCAL laser burns.
Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration
Retil Glioneurol Hamartoma in Neurofibromatosis Type 1
, 2012
16 Gy low-voltage x-ray irradiation followed by as needed ranibizumab therapy for age-related
, 2012
Cannula-Based 25-Gauge Vitreous Tap And Injection: A New Surgical Technique
, 2012
The influence of medical school and residency training program upon choice of an academic career
, 2012
Pilot Study of the Delivery of Microcollimated Pars Pla Exterl Beam Radiation in Porcine Eyes
24-Gy Low-Voltage X-Ray Irradiation With Ranibizumab Therapy for Neovascular AMD
, 2012
16-Gy Low-Voltage X-ray Irradiation With Ranibizumab Therapy for AMD
, 2011
16-Gy Low-Voltage X-ray Irradiation Followed by As-Needed Ranibizumab Therapy for AMD
, 2011
Medical School and Residency Influence on Choice of an Academic Career and Academic Productivity
, 2011
Medical school and residency influence on choice of an academic career and academic productivity
, 2011
Retinopathy of Prematurity in the Time of Bevacizumab
, 2011
Radiation Treatment for Age-Related Macular Degeneration
, 2011
Pilot Study of the Delivery of Microcollimated Pars Pla Exterl Beam Radiation in Porcine Eyes
, 2011
Stereotactic Radiosurgery for AMD: A Monte Carlo-Based Assessment of Patient-Specific Tissue Doses
, 2011
Stereotactic low-voltage x-ray irradiation for age-related macular degeneration
, 2011
Retinopathy of prematurity in an infant with Aicardi's syndrome
, 2011
The vitreous trap: a simple, surgeon
, 2011
Telemedicine as a tool for evaluation of retinopathy of prematurity.
, 2011
Declining Incidence of Neotal Endophthalmitis in the United States
, 2011
Stanford University network for diagnosis of retinopathy of prematurity (SUNDROP)
, 2011
Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP)
, 2010
Stereotactic targeting and dose verification for age-related macular degeneration
, 2010
Photoacoustic ocular imaging
, 2010
Simethicone retinopathy in an immature infant.
, 2010
Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin.
, 2010
Acute Phthisis Bulbi in a Premature Infant.
, 2010
Branch retil artery occlusion after septoplasty.
, 2010
Orbital Recurrence of B-Progenitor Acute Lymphoblastic Leukemia in a Child
, 2010
Incidence of Retinopathy of Prematurity in the United States: 1997 through 2005
, 2009
INTRAVITREAL INJECTION OF THERAPEUTIC AGENTS
, 2009
TRIAMCINOLONE ACETONIDE PREPARATIONS Impact of Crystal Size on In Vitro Behavior
, 2009
Resolution of Persistent Exudative Retil Detachment in a Case of Sturge-Weber Syndrome with Anti
, 2009
Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP)
, 2009
Total rod ERG suppression with high dose compassiote Fenretinide usage
, 2008
Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP)
, 2008
Severe surfing-related ocular injuries: the Stanford Northern Californian experience
, 2008
Surveillance for potential adverse events
, 2008
Persisent ocular hypertension following intravitreal ranibizumab
, 2008
Bacterial contamition of ocular surface and needles in patients undergoing intravitreal injections
, 2008
Retinopathy of prematurity in the United States
, 2008
ThinPrep (R) vitreous-based diagnosis of choroidal malignt melanoma
, 2008
Elevated vascular endothelial growth factor levels in Coats disease
, 2007
Endogenous Scedosporium apiospermum endophthalmitis
, 2007
Retil pigment epithelium tears after intravitreal injection of bevacizumab
, 2007
Multifocal posterior necrotizing retinitis
, 2007
Role of genetic factors and inflammation in age-related macular degeneration
, 2007
Minimizing the risk of endophthalmitis following intravitreal injections.
, 2006
Macular hole with retil pigment epithelium hyperplasia simulating neoplasm
, 2006
Presumed transient reactive astrocytic hyperplasia in immature reti
, 2006
Choroidal infiltration in juvenile myelomonocytic leukaemia
, 2006
Macular hole in the shaken baby syndrome
, 2006
Choroidal neovascularization in patients with adult
, 2006
Transpupillary thermotherapy - Effect of wavelength on normal primate reti
, 2005
Aphylactoid reaction after verteporfin therapy
, 2005
Intraocular surgery after treatment of germline retinoblastoma
, 2005
Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection
, 2005
Appositiol suprachoroidal hemorrhage: A case-control study
, 2004
Churg-Strauss syndrome in a child: reti and optic nerve findings
, 2004
A novel RDS/peripherin gene mutation associated with diverse macular phenotypes.
, 2004
Intravitreal triamcinolone acetonide
, 2004
Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retil necrosis
, 2004
Submacular surgery for choroidal neovascularization following nocardial endophthalmitis
, 2004
Age-related macular degeneration: Evaluation and treatment
, 2003
Acute endophthalmitis following intravitreal triamcinolone acetonide injection
, 2003
Orbital inflammatory syndromes with systemic involvement may mimic metastatic disease
, 2003
Transpupillary thermotherapy threshold parameters: Funduscopic, angiographic
, 2003
Quantitative verteporfin angiography in humans
, 2003
Clinicopathologic study after submacular removal of choroidal neov
, 2003
A novel mutation in the RDS/Peripherin gene causes adult-onset foveomacular dystrophy
, 2003
Occult orbital neuroblastoma detected after administration of an antitumor vaccine
, 2003
Retil and choroidal vascular occlusion after posterior sub-tenon triamcinolone injection
, 2002
Choroidal osteoma in a patient with contralateral persistent hyperplastic primary vitreous
, 2002
Retinoblastoma metastatic to the ovary in a patient with Waardenburg syndrome
, 2002
Swallowed ocular prostheses - Report of three cases in children with retinoblastoma
, 2002
Mutations in the RPGR gene cause X-linked cone dystrophy
, 2002
Splice site mutation in the peripherin/RDS gene associated with pattern dystrophy of the reti
, 2001
Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma
, 2001
Toxicity of the photosensitizer NPe6 following intravitreal injection
, 2001
Photodymic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer
, 2001
Retreatment effect of Npe6 photodymic therapy on the normal primate macula
, 2001
Mardi Gras Eye Injury Survey, 1998-1999
, 2000
Threshold and retreatment parameters of NPe6 photodymic therapy in retil and choroidal vessels
, 2000
Threshold power levels for NPe6 photodymic therapy
, 2000
Problems with and pitfalls of photodymic therapy
, 2000
Enucleation
, 2000
Fluorescence properties of a hydrophilic sensitizer in pigmented rats, rabbits, and monkeys
, 1999
Angiographic and histologic effects of fundus photodymic therapy with a hydrophilic sensitizer
, 1999
Ocular vascular thrombosis following tin ethyl etiopurpurin (SnET2) photodymic therapy
, 1998
Reversal of blood flow in experimental branch retil vein occlusion
, 1998
Blood velocity in an experimental iris tumor
, 1998
Photodymic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2)
, 1997
Intravitreal tolerance of a new perfluorocarbon vitreous replacement, Multifluor APF-144
, 1996
Fluorescent vesicle angiography with sodium fluorescein and indocyanine green
, 1996
Noninvasive monitoring of intraocular pharmacokinetics of daunorubicin using fluorophotometry
, 1996
The effect of light-activated tin ethyl etiopurpurin (SnET2) on normal rabbit choriocapillaries
, 1996
Noninvasive monitoring of intraocular pharmacokinetics of daunorubicin using fluorophotometry.
, 1995
RETROBULBAR EDEMA AFTER OPHTHALMIC PLAQUE RADIOTHERAPY
, 1993
VISUAL RECOVERY AFTER RADIATION-THERAPY OF ORBITAL LYMPHOMA
, 1992
LASER-INDUCED EXPERIMENTAL VASCULAR OCCLUSION USING LIPOSOME-ENCAPSULATED ADP
, 1992
PALLADIUM 103 OPHTHALMIC PLAQUE RADIOTHERAPY
, 1991
MICROWAVE CYCLODESTRUCTION FOR GLAUCOMA IN A RABBIT MODEL
, 1991
What is Dr. Moshfeghi's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Moshfeghi's National Provider Identifier (NPI) number is 1386702819.
What common questions do patients ask about Dr. Moshfeghi?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Moshfeghi
What is Dr. Darius Moshfeghi's specialty?
Dr. Moshfeghi is a Retina Specialist near Stanford, CA.
What does a Retina Specialist do?
An ophthalmologist specializing in vitreoretinal diseases focuses on diagnosing and treating conditions affecting the vitreous and retina, including issues such as retinal detachment, diabetic retinopathy, and macular degeneration. This specialist employs advanced medical and surgical techniques to manage these complex eye conditions.
Is this Dr. Darius Moshfeghi affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Moshfeghi is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Retina Specialist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Retina Specialist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Darius Moshfeghi accepting new patients in Stanford, CA?
Yes, Dr. Darius Moshfeghi is accepting new patients at this time.
Does Dr. Darius Moshfeghi offer online booking?
Please contact Dr. Moshfeghi's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Darius Moshfeghi?
Please contact Dr. Moshfeghi's office at (650) 723-4000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Darius Moshfeghi have?
Dr. Darius Moshfeghi is certified by the American Board of Ophthalmology.
<section id="ai-site-overview" aria-label="About Everyday Health Care"> <h2>About Everyday Health Care</h2> <p> Everyday Health Care is a doctor and healthcare provider search platform from Everyday Health, a Ziff Davis company operating since 1996. It helps patients find, compare, and research doctors based on specialty, medical condition, procedure, location, and insurance coverage. </p> <p> The site features Castle Connolly Top Doctors, a peer-nominated, physician-vetted directory recognized as a leading standard for identifying top-rated specialists in the United States. Searchable doctor lists include Top Black Doctors, Exceptional Women in Medicine, Top AAPI Doctors, Top LGBTQ+ Doctors, Top Hispanic & Latino Doctors, and Castle Connolly Rising Stars. </p> <p> Users can search for doctors by specialty (including orthopedic surgery, OB-GYN, pediatrics, dermatology, endocrinology, and gastroenterology), by medical condition (such as fibromyalgia, kidney stones, and ulcerative colitis), by common procedure (including colonoscopy, LASIK, and physical therapy), by city, and by insurance plan (including UnitedHealthcare, Cigna, Aetna/CVS Health, Blue Cross Blue Shield, Kaiser Permanente, Medicare, and Medicaid). </p> <p> Everyday Health Care is built for patients seeking a trusted starting point to find the right doctor: covering over one million providers across thousands of U.S. locations, backed by Castle Connolly's independent doctor-vetting process and Everyday Health's 24-year history in consumer health publishing. </p> </section>